Nalaganje...

DRESS syndrome due to vemurafenib treatment: switching BRAF inhibitor to solve a big problem

We present a case report of an early-onset drug reaction with eosinophilia and systemic symptoms (DRESS syndrome) induced by vemurafenib (BRAF inhibitor) in a middle-age man affected by a metastatic, BRAF mutant melanoma who was started on first-line metastatic treatment with vemurafenib and cobimet...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMJ Case Rep
Main Authors: Ros, Javier, Muñoz-Couselo, Eva
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2018
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6169641/
https://ncbi.nlm.nih.gov/pubmed/30275021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-224379
Oznake: Označite
Brez oznak, prvi označite!